Steroid-refractory immune related hepatitis may hide viral re-activation

Cancer immunotherapy has become a stronghold in modern oncology. Immune checkpoint inhibitors, in particular anti-PD-1 and anti-PD-L1 antibodies, are approved for the treatment of several solid cancers. In the near future, an increasing number of patients will be eligible for immunotherapy. Therefor...

Descripción completa

Detalles Bibliográficos
Autores principales: Citarella, Fabrizio, Galletti, Alessandro, Russano, Marco, Gallo, Paolo, Vespasiani-Gentilucci, Umberto, Picardi, Antonio, Tonini, Giuseppe, Vincenzi, Bruno, Santini, Daniele
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Future Science Ltd 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7668132/
https://www.ncbi.nlm.nih.gov/pubmed/33235808
http://dx.doi.org/10.2144/fsoa-2020-0056

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7668132/
https://www.ncbi.nlm.nih.gov/pubmed/33235808
http://dx.doi.org/10.2144/fsoa-2020-0056

Ejemplares similares